QNRX CIK: 1671502

Quoin Pharmaceuticals Ltd.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−5.72
FY22:
−8.48
FY23:
−7.86
FY24:
−7.86
FY25:
−13.5
Change from FY21 to FY25
millions USD
FY21:
−0.63
FY22:
−10.1
FY23:
2.19
FY24:
−1.89
FY25:
−4.28
Change from FY21 to FY25
millions USD
FY21:
13.5
FY22:
14.0
FY23:
5.22
FY24:
11.0
FY25:
18.0
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
1.22
FY25:
0.19
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
−13.5

All amounts in millions USD Data sources:SEC EDGARTwelve Data